Adjuvant Chemotherapy

Subscribe to Selected New Research on Adjuvant Chemotherapy

6165 relevant articles (582 outcomes, 1292 trials/studies) found for this Therapy

Description: Drug therapy given to augment or stimulate some other form of treatment such as surgery or radiation therapy. Adjuvant chemotherapy is commonly used in the therapy of cancer and can be administered before or after the primary treatment.

Also Known As:

Chemotherapy, Adjuvant; Adjuvant Drug Therapy; Drug Therapy, Adjuvant

Relationship Network

Therapy Context: Research Results

Therapeutics: 5229

Drug Therapy: 116907

Adjuvant Chemotherapy: 6165

Combined Modality Therapy: 1510

Adjuvant Chemotherapy: 6165

Experts

1.	Norton, Larry: 11 articles (05/2008 - 03/2003)
2.	Hortobagyi, Gabriel N: 9 articles (10/2008 - 05/2002)
3.	Hudis, Clifford: 9 articles (01/2008 - 01/2005)
4.	Le Chevalier, Thierry: 9 articles (07/2007 - 01/2004)
5.	Goldhirsch, Aron: 8 articles (07/2007 - 04/2003)
6.	Wolmark, Norman: 7 articles (06/2008 - 11/2004)
7.	Gelber, Richard D: 7 articles (06/2008 - 12/2003)
8.	Cognetti, Francesco: 7 articles (03/2008 - 10/2003)
9.	Shepherd, Frances A: 7 articles (12/2007 - 03/2005)
10.	Hurria, Arti: 7 articles (07/2007 - 01/2005)

Related Diseases

1.	Neoplasms (Cancer) 01/01/2001 - "Adjuvant chemotherapy may prove effective in reducing the postoperative recurrence but at this stage surgery still remains as the best treatment for patients with recurrent tumor which is accessible to resection." 01/01/2000 - "The adjuvant chemotherapy performance was most effective in cancer stage III and in nondifferentiated type of tumor." 10/29/1991 - "The chances to be cured from a primary malignant musculoskeletal tumor have improved dramatically during the last two decades with the introduction of adjuvant chemotherapy" 08/01/1984 - "Extirpative surgery followed by adjuvant chemotherapy and occasionally radiation therapy was most effective for local tumor control and 7 of 10 patients survived, including 5 with an intact functional bladder" 07/01/1979 - "The treatment plan which seems to show the best results consists of preoperative irradiation with adjuvant chemotherapy followed by surgical removal of the tumor" Order ALL the reference details at left...
2.	Breast Neoplasms (Breast Cancer) 01/01/1990 - "Adjuvant chemotherapy is a well accepted concept in the treatment of breast cancer and has resulted in most clinical studies in a significant prolongation of the disease-free interval in certain subgroups of patients" 12/01/2005 - "Adjuvant chemotherapy is most cost-effective in pre-menopausal women with node-positive breast cancer while cost-effectiveness decreases considerably with increasing age" 01/01/2001 - "The proven benefits of adjuvant chemotherapy on disease-free and overall survival in breast cancer can be explained by concepts of cell kill" 07/01/2004 - "AIM AND BACKGROUND: The aim of this study was to investigate the efficacy of postoperative locoregional radiotherapy in patients with T1-T2 breast cancer and four or more positive axillary lymph nodes submitted to mastectomy or breast-conserving surgery followed by standard-dose or high-dose adjuvant chemotherapy" 01/01/2001 - "PATIENTS AND METHODS: From a randomized study in high-risk breast cancer patients on the efficacy of high-dose versus standard-dose adjuvant chemotherapy, late effects on cognitive functioning were analyzed by neuropsychological tests" Order ALL the reference details at left...
3.	Neoplasm Metastasis (Metastasis) 01/01/2004 - "Neoadjuvant or adjuvant chemotherapy did not provide a significant survival advantage, although adjuvant chemotherapy improved the 5-year overall survival in patients with pathologically proven lymph node metastasis" 02/01/2008 - "Treatment-related variables such as repeat resections in the event of liver recurrence (P < .01) or lung metastases (P < .05), as well as adjuvant chemotherapy (P < .01), differed significantly between 3-year survivors and nonsurvivors, as did the differences in number of metastases, maximum size of metastases, concomitant extrahepatic metastases at the time of initial hepatectomy, and disease-free interval preceding initial recurrence" 12/01/1998 - "CONCLUSIONS: Adjuvant chemotherapy significantly improved survival and disease-free survival after hepatic resection for colorectal metastases" 12/01/1998 - "The multivariate analysis for disease-free survival selected adjuvant chemotherapy, lymph node metastasis, and disease-free interval as significant factors" 07/01/1994 - "Adjuvant chemotherapy however reduces significantly the risk of distant metastases and--although there is no influence on the risk for locoregional relapse--increases significantly the chance for total disease-free and overall survival" Order ALL the reference details at left...
4.	Colorectal Neoplasms (Colorectal Cancer) 12/01/2008 - "This study aimed to retrospectively assess the efficacy of postoperative adjuvant chemotherapy in 77 patients who underwent curative resection for stage III colorectal cancer" 11/01/2008 - "The present study was designed to retrospectively examine the efficacy of postoperative adjuvant chemotherapy in 107 patients with stage II primary colorectal cancer who underwent curative resection" 03/01/2002 - "Efficacy of oral UFT as adjuvant chemotherapy to curative resection of colorectal cancer: multicenter prospective randomized trial." 04/01/2007 - "Although adjuvant chemotherapy is the standard practice for patients with stages I-III breast and colorectal cancer, the therapeutic efficacy of adjuvant chemotherapy, following complete surgical resection of early stage NSCLC, has not been fully established" 01/01/2002 - "To investigate the efficacy of the adjuvant chemotherapy, we retrospectively reviewed all 293 colorectal cancer patients who underwent curative resection between 1990 and 1996 in Kurume University Hospital" Order ALL the reference details at left...
5.	Carcinoma (Carcinomatosis) 07/01/2008 - "S-1, a most effective DPD-inhibitory fluoropyrimidine, used as neoadjuvant/adjuvant chemotherapy has recently been shown to improve clinical outcome in patients with stage II and III advanced stage gastric carcinoma" 12/01/1987 - "Because the follow-up of these patients suggests a marked improvement in outcome compared with similar patients treated traditionally with mastectomy or radiotherapy followed by adjuvant chemotherapy, we advocate more widespread use of combination chemotherapy before definitive treatment for stage III carcinomas of the breast." 08/15/1986 - "A retrospective analysis comparing those patients who received full-neck irradiation and adjuvant chemotherapy with those who received full-neck irradiation alone showed a significantly improved survival (P less than 0.02) and disease-free survival (P less than 0.05) for those patients with undifferentiated carcinomas, including lymphoepitheliomas, who received adjuvant chemotherapy." 02/01/1995 - "Thus, we believe that the main therapy for subglottic carcinoma, except T1, should be surgery to obtain a better outcome, and that adjuvant chemotherapy after irradiation or neck (paratracheal) dissection with total laryngectomy should be performed in advanced cases." 07/01/1981 - "The data on adjuvant chemotherapy for mammary carcinoma obtained from animal models suggest that (a) systemic chemotherapy combined with tumour excision provides more long-term cures than either method alone, (b) systemic treatment may be effective in eradicating occult micrometastases and (c) the effect of systemic chemotherapy decreases with advancing tumour stage preoperatively, with increasing time lag between operation and chemotherapy, and as the drug dosage decreases" Order ALL the reference details at left...

Related Drugs and Biologics

1.	Fluorouracil (Carac)
2.	Doxorubicin (Adriamycin)
3.	Cyclophosphamide (Cytoxan)
4.	Cisplatin (Platino)
5.	Methotrexate (Mexate)
6.	Tegafur
7.	Leucovorin (Folinic Acid)
8.	Paclitaxel (Taxol)
9.	1-hexylcarbamoyl-5-fluorouracil (carmofur)
10.	Hormones

Related Therapies and Procedures

1.	Drug Therapy (Chemotherapy)
2.	Combination Drug Therapy (Combination Chemotherapy)
3.	Cystectomy
4.	Adjuvant Radiotherapy
5.	Mastectomy (Mammectomy)

Best Treatments:
Research Summary Report
on Neoplasms

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 18530 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>